MS Speaks
Here for 17 years--for people with an interest in multiple sclerosis
Welcome,
Guest
. Please
login
or
register
.
1 Hour
1 Day
1 Week
1 Month
Forever
Login with username, password and session length
This topic
This board
Entire forum
Home
Search
Today's Posts
Contact
Login
Register
MS Speaks 5/06 to 11/13
MS Speaks
»
Forum
»
Multiple Sclerosis
»
TREATMENTS
»
LEMTRADA (Campath, alemtuzumab)
»
FDA rejects MS drug Lemtrada (alemtuzumab, Campath)
»
Message #145
« previous
next »
Print
Pages: [
1
]
Author
Topic: FDA rejects MS drug Lemtrada (alemtuzumab, Campath) (Read 314 times)
0 Members and 1 Guest are viewing this topic.
agate
Administrator
Posts: 9822
MS diagnosed 1980
Location: Pacific Northwest
Re: FDA rejects MS drug Lemtrada (alemtuzumab, Campath)
«
on:
January 31, 2014, 04:21:36 pm »
The FDA's rejection of Lemtrada has surprised and angered MS doctors and patients, according to
this blog article in MedPage Today
, January 23, 2014.
Report to moderator
Logged
MS Speaks--online for 17 years
SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Print
Pages: [
1
]
« previous
next »
MS Speaks
»
Forum
»
Multiple Sclerosis
»
TREATMENTS
»
LEMTRADA (Campath, alemtuzumab)
»
FDA rejects MS drug Lemtrada (alemtuzumab, Campath)
»
Message #145